290 related articles for article (PubMed ID: 36350460)
1. Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection.
Ghanaim AM; Foaad MA; Gomaa EZ; Dougdoug KAE; Mohamed GE; Arisha AH; Khamis T
Int Microbiol; 2023 May; 26(2):343-359. PubMed ID: 36350460
[TBL] [Abstract][Full Text] [Related]
2. The Healing Capability of Clove Flower Extract (CFE) in Streptozotocin-Induced (STZ-Induced) Diabetic Rat Wounds Infected with Multidrug Resistant Bacteria.
Ali R; Khamis T; Enan G; El-Didamony G; Sitohy B; Abdel-Fattah G
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408668
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial effects of single phage and phage cocktail against multidrug-resistant Klebsiella pneumoniae isolated from diabetic foot ulcer.
Jokar J; Saleh RO; Rahimian N; Ghasemian A; Ghaznavi G; Radfar A; Zarenezhad E; Najafipour S
Virus Genes; 2023 Aug; 59(4):635-642. PubMed ID: 37259013
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model.
Jokar J; Abdulabbas HT; Javanmardi K; Mobasher MA; Jafari S; Ghasemian A; Rahimian N; Zarenezhad A; ُSoltani Hekmat A
Virus Genes; 2024 Feb; 60(1):80-96. PubMed ID: 38079060
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing Staphylococcus aureus Virulence with AZD6389, a Three mAb Combination, Accelerates Closure of a Diabetic Polymicrobial Wound.
Tkaczyk C; Jones-Nelson O; Shi YY; Tabor DE; Cheng L; Zhang T; Sellman BR
mSphere; 2022 Jun; 7(3):e0013022. PubMed ID: 35642538
[TBL] [Abstract][Full Text] [Related]
7. Nasal MRSA carriage is a risk factor for development of antibiotic resistance in diabetic foot ulcers and is significantly higher than diabetic and non-diabetic individuals without foot ulcer.
Mukherjee P; Paul S; Dutta T; Nath S; Ghosh B; Chatterjee D; Mukhopadhyay S; Mukherjee S
BMC Infect Dis; 2023 Oct; 23(1):729. PubMed ID: 37884870
[TBL] [Abstract][Full Text] [Related]
8. Identification of contributing factors, microorganisms and antimicrobial resistance involved in the complication of diabetic foot ulcer treatment.
Khan MS; Azam M; Khan MN; Syed F; Ali SHB; Malik TA; Alnasser SMA; Ahmad A; Karimulla S; Qamar R
Microb Pathog; 2023 Nov; 184():106363. PubMed ID: 37730169
[TBL] [Abstract][Full Text] [Related]
9. A Study on Isolation, Characterization, and Exploration of Multiantibiotic-Resistant Bacteria in the Wound Site of Diabetic Foot Ulcer Patients.
Thanganadar Appapalam S; Muniyan A; Vasanthi Mohan K; Panchamoorthy R
Int J Low Extrem Wounds; 2021 Mar; 20(1):6-14. PubMed ID: 31735111
[TBL] [Abstract][Full Text] [Related]
10. Infection Characteristics and Drug Susceptibility of Multidrug-Resistant Bacteria in Patients with Diabetic Foot Ulcers.
Chen T; Yu J; Ye J; Mu Q; Chang Q; Wu R; Qian C
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702668
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-κB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2.
Sun X; Wang X; Zhao Z; Chen J; Li C; Zhao G
Drug Dev Res; 2021 May; 82(3):404-411. PubMed ID: 33236457
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage Treatment of Infected Diabetic Foot Ulcers.
Morozova VV; Kozlova YN; Ganichev DA; Tikunova NV
Methods Mol Biol; 2024; 2734():197-205. PubMed ID: 38066371
[TBL] [Abstract][Full Text] [Related]
13. Effects of pH on the Antibiotic Resistance of Bacteria Recovered from Diabetic Foot Ulcer Fluid
McArdle CD; Lagan KM; McDowell DA
J Am Podiatr Med Assoc; 2018 Jan; 108(1):6-11. PubMed ID: 29547034
[TBL] [Abstract][Full Text] [Related]
14. Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia.
Atlaw A; Kebede HB; Abdela AA; Woldeamanuel Y
Front Endocrinol (Lausanne); 2022; 13():987487. PubMed ID: 36120451
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
16. Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.
OuYang H; Tang Y; Yang F; Ren X; Yang J; Cao H; Yin Y
Front Endocrinol (Lausanne); 2023; 14():1256081. PubMed ID: 38169990
[TBL] [Abstract][Full Text] [Related]
17. Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
Chhibber S; Kaur T; Sandeep Kaur
PLoS One; 2013; 8(2):e56022. PubMed ID: 23418497
[TBL] [Abstract][Full Text] [Related]
18. CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England.
Nelson A; Wright-Hughes A; Backhouse MR; Lipsky BA; Nixon J; Bhogal MS; Reynolds C; Brown S;
BMJ Open; 2018 Jan; 8(1):e019437. PubMed ID: 29391370
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
[TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin accelerates foot wound healing in diabetic rats though activating the Nrf2 pathway.
Sun X; Wang X; Zhao Z; Chen J; Li C; Zhao G
Acta Histochem; 2020 Dec; 122(8):151649. PubMed ID: 33166863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
